Posted: January 10th, 2023
Tumor Necrosis Factor (TNF) Inhibitors Essay
Tumor Necrosing factor inhibitors (biologics) are used for the treatment of inflammatory bowel disease. Explain the indications, ADR’s, monitoring, and patient education for these drugs please use peer-reviewed articles as well as professional articles this is per instructor.
Tumor Necrosis Factor (TNF) Inhibitors
Course Code, Course Name
Tumor Necrosis Factor Inhibitors
Inhibitors of Tumor necrosis factor (TNF) are agents such as adalimumab, infliximab, and golimumab. They are a class of biological agents approved by the FDA for management of disorders such as, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis, and Crohn disease, among other diseases, exacerbated by the action of TNF. Other clinicians use it off-label for the management of sarcoidosis, Behcet disease, and graft versus host disease. The agents block the inflammatory process mediated by TNF (Gerriets, 2020) Tumor Necrosis Factor (TNF) Inhibitors Essay. Such include the activation of leukocytes through signaling pathway resulting in transcription of protein kinases and proteases. This leads to immunomodulation by stimulating apoptosis of immune cells and inhibiting the T lymphocytes.
The medication may cause both mild and severe side effects. Minor adverse reactions do not require termination of medication. They can manifest in the form of rashes, headache, abdominal pain, sinusitis, nausea, and diarrhea. Serious effects that may occur fare those associated with immunosuppression where patients get predisposed to infections by fungi, viruses, or bacteria. In severe cases, this can be fatal. Studies indicate reactivation of latent tuberculosis in some patients. Additionally, there is increased risk of malignancy more so lymphomas (Salomon, 2018). Therapy associated Lupus and Congestive cardiac failure are other side effects that may be fatal if not addressed. Tumor Necrosis Factor (TNF) Inhibitors Essay Its most significant contraindication is in patients with known hypersensitivity to the drugs.
Before administration, patients should get comprehensive information on the pros and cons of the medication. A full disclosure of the possible side effects is necessary. Furthermore, the process of administration and condition surrounding the same are explained. Monitoring is performed prior to, during and post medication. The recommendation time-duration for monitoring is every three to six months with liver function tests and blood counts (Papamichael, 2019). Current evidence also recommends that clinicians should advice patients against getting any vaccination during the course of management with TNF inhibitors Tumor Necrosis Factor (TNF) Inhibitors Essay.
Gerriets, V., Bansal, P., Goyal, A., & Khaddour, K. (2020). Tumor necrosis factor inhibitors. StatPearls [internet].
Papamichael, K., Vogelzang, E. H., Lambert, J., Wolbink, G., & Cheifetz, A. S. (2019). Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases. Expert review of clinical immunology, 15(8), 837-848.
Salomon, B. L., Leclerc, M., Tosello, J., Ronin, E., Piaggio, E., & Cohen, J. L. (2018). Tumor necrosis factor α and regulatory T cells in oncoimmunology. Frontiers in immunology, 9, 444 Tumor Necrosis Factor (TNF) Inhibitors Essay.
Place an order in 3 easy steps. Takes less than 5 mins.